1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. SAGE THERAPEUTICS INC
Sage Therapeutics Inc XNAS: SAGE

Sage Therapeutics Inc - SAGE - stock price prediction, stock price target, analyst ratings from 13 analysts

Sage Therapeutics Inc has a share price target of US$ 9, revenue growth forecast of 104.2%, and profit growth estimate of 46.0% for FY25, based on top 13 analyst calls.